National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$32.00
add to cart

Rights & Permissions

topleft topright

Assessment of Future Scientific Needs for Live Variola Virus (1999)
Institute of Medicine (IOM)

Citation Manager

. "Appendix B Acronyms." Assessment of Future Scientific Needs for Live Variola Virus. Washington, DC: The National Academies Press, 1999.

Please select a format:

BibTeX EndNote RefMan


Page
99
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Appendix B
Acronyms


BSL-4:

Biological Safety Level 4


CDC:

Centers for Disease Control and Prevention, Atlanta, Ga.

CMV:

Cytomegalovirus

COI:

World Health Organization Committee on Orthopox Infections


DHHS:

U.S. Department of Health and Human Services

DOD:

U.S. Department of Defense

DOE:

U.S. Department of Energy


EEV:

Extracellular Enveloped Virus


FDA:

U.S. Federal Drug Administration


HA:

Hemagglutinin antigen

HEPA (filters):

High-efficiency particulate air (filters)

HI:

Hemagglutinin-inhibiting

HIV:

Human immunodeficiency virus.

HPMPA:

((S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine)


IMV:

Intracellular Mature Virus

IND:

Investigational new drug


JCG:

Joint coordinating group


NIH:

National Institutes of Health

NYCBH:

New York City Board of Health


PCR:

Polymerase chain reaction.

PMEA:

Adefovir, 9-[2-(phosphonomethoxy)ethyl]adenine)


RLFP:

Restriction fragment length


UDG:

Uracil DNA glycosylase

USAMRIID:

U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick., Md.

Page
99

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 99
--> Appendix B Acronyms BSL-4: Biological Safety Level 4 CDC: Centers for Disease Control and Prevention, Atlanta, Ga. CMV: Cytomegalovirus COI: World Health Organization Committee on Orthopox Infections DHHS: U.S. Department of Health and Human Services DOD: U.S. Department of Defense DOE: U.S. Department of Energy EEV: Extracellular Enveloped Virus FDA: U.S. Federal Drug Administration HA: Hemagglutinin antigen HEPA (filters): High-efficiency particulate air (filters) HI: Hemagglutinin-inhibiting HIV: Human immunodeficiency virus. HPMPA: ((S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine) IMV: Intracellular Mature Virus IND: Investigational new drug JCG: Joint coordinating group NIH: National Institutes of Health NYCBH: New York City Board of Health PCR: Polymerase chain reaction. PMEA: Adefovir, 9-[2-(phosphonomethoxy)ethyl]adenine) RLFP: Restriction fragment length UDG: Uracil DNA glycosylase USAMRIID: U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick., Md.

OCR for page 100
--> VECTOR: State Center of Virology and Biotechnology, Koltsovo, Russia VIG: Vaccinia Immune globulin WHA: World Health Assembly WHO: World Health Organization

Representative terms from entire chapter:

enveloped virus